Search

everythinglearnresearchcommunity

for

Search:↓

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Activated PRP is unnecessary for treating alopecia areata; both activated and non-activated PRP are equally effective and safe.

Certain histamine receptors (H2R, H3R, H4R) have unique roles in treating skin diseases, with H2R helping with chronic urticaria and other conditions, H3R providing pain relief and allergy benefits, and H4R reducing inflammation and itchiness.

Ustekinumab helped three kids with alopecia areata regrow hair.

A skin rash after the AstraZeneca COVID-19 vaccine was treated successfully with medication.

Probiotics significantly reduce the severity of atopic dermatitis.

Engineered cytokines show promise for improving tissue healing and safety in regenerative medicine.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

Adalimumab helped control a child's severe eye disease when other treatments failed.

The patient had a severe allergic reaction to gold treatment.

The role of γδT-cells in causing alopecia areata remains unclear.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

PRP works faster and is a safe alternative to steroids for treating alopecia areata.

BCG site reactions after COVID-19 mRNA vaccination are mild, temporary, and likely under-reported.

RCS-01 therapy is safe and may improve skin structure by affecting gene expression.

RG and RJ gels speed up burn wound healing better than other treatments.

Dermatologists should consider alpha-gal syndrome in patients with unexplained chronic skin issues.

Researchers successfully made new compounds for hormone level tests, but one attempt led to an unexpected product, correcting a past error.

The botanical treatment for hair loss shows promise, especially for children.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

New treatments for atopic dermatitis and alopecia areata have been developed using a targeted approach.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

A new hydrogel with micronized amnion helps achieve better, scar-free skin healing.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Intralesional Triamcinolone acetonide injections are safe and effective for treating alopecia areata.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.